Petzold, Axel;
(2023)
Remyelination.
Presented at: Jubilee Congress celebrating the 90th anniversary of founding the Polish Neurological Society, Warsaw, Poland.
Preview |
Slideshow
2023-Remyelination-Warsaw.pdf - Submitted Version Download (2MB) | Preview |
Abstract
Dr. Axel Petzold MD PhD FRCP FRCOphth FRCPath is a distinguished consultant neurologist with appointments at renowned institutions, including the National Hospital for Neurology and Neurosurgery (UCLH NHNN) in Queen Square, London, Moorfields Eye Hospital (MEH) on City Road, London, and the prestigious Amsterdam University Medical Centre in The Netherlands. His extensive expertise encompasses clinical and research domains, with a particular focus on multiple sclerosis, optic neuritis, neurodegeneration, and neuro-critical care. Dr. Petzold's research endeavors seamlessly bridge clinical studies and trials with cutting-edge imaging and biomarker investigations. His commitment to advancing the field is underscored by his prestigious fellowship memberships in the Royal College of Physicians (2019), Royal College of Ophthalmologists (2021), and Royal College of Pathology (2021). Throughout his illustrious career, Dr. Petzold has held key leadership positions, including Chair for Neuro-Ophthalmology in the European Reference Networks for Rare Diseases from 2016 to 2020. He has also been an instrumental figure on the Board of Directors for IMSVISUAL and serves as a Steering Committee member of the United Kingdom BioBank Eye and Vision Consortium. One of Dr. Petzold's notable achievements has been the establishment and oversight of integrated care pathways between Moorfields Eye Hospital and UCLH NHNN. These pathways cover a wide spectrum of conditions, including demyelinating diseases, dementia, autoimmune conditions, transient ischemic attacks (TIAs), and stroke. Dr. Petzold's scholarly impact is profound, with a robust publication record comprising 317 articles in peer-reviewed journals, including 105 as the first author. The cumulative impact factor of his work stands at an impressive 1938, and he maintains a noteworthy Google Scholar H-Index of 73. He has also contributed to the academic community by compiling two books, one monograph, and authoring 14 book chapters, including 10 as the first author. His dedication to the peer review process is evident through his extensive reviewer record, with 528 verified peer reviews accessible on the Web of Science (Researcher ID: C-1090-2009). Notably, Dr. Petzold has played a pivotal role in training visiting research fellows from abroad, with seven of them currently holding prestigious academic chairs in their home universities. Dr. Petzold's contributions extend beyond his academic achievements. He has been at the forefront of validation and quality control strategies and has played a crucial role in the development of frequently cited reporting guidelines. Additionally, his work with spectral domain optical coherence tomography has been instrumental in integrating this vital imaging technique into diverse research lines across multiple disciplines. Dr. Petzold's dedication to education and mentorship is exemplified through his supervision of PhD students and active participation in clinical trials. He continues to provide virtual clinical care in neuro-ophthalmology in Amsterdam, ensuring global access to his expertise. Clinically, Dr. Petzold's impact is far-reaching, as he has trained fellows from around the world in neuro-ophthalmology. His unique approach combines acute patient care at Moorfields Eye Hospital, City Road, with the highly specialised tertiary care offered at The National Hospital for Neurology and Neurosurgery, Queen Square. Dr. Axel Petzold's illustrious career and multidisciplinary contributions have significantly advanced our understanding of neurology and neuro-ophthalmology. His dedication to research, education, and clinical care continues to shape the landscape of these fields on a global scale.
Archive Staff Only
 |
View Item |
